Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 4

Results: 10

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 455, doi. 10.1002/cac2.12414
By:
- Eun, Jung Woo;
- Yoon, Jung Hwan;
- Ahn, Hye Ri;
- Kim, Seokhwi;
- Kim, Young Bae;
- Lim, Su Bin;
- Park, Won;
- Kang, Tae Wook;
- Baek, Geum Ok;
- Yoon, Moon Gyeong;
- Son, Ju A;
- Weon, Ji Hyang;
- Kim, Soon Sun;
- Cho, Hyo Jung;
- Cheong, Jae Youn
Publication type:
Article
N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 480, doi. 10.1002/cac2.12413
By:
- Miao, Daojia;
- Wang, Qi;
- Shi, Jian;
- Lv, Qingyang;
- Tan, Diaoyi;
- Zhao, Chuanyi;
- Xiong, Zhiyong;
- Zhang, Xiaoping
Publication type:
Article
Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 435, doi. 10.1002/cac2.12412
By:
- Liu, Chaofan;
- Wang, Xi;
- Qin, Wan;
- Tu, Jingyao;
- Li, Chunya;
- Zhao, Weiheng;
- Ma, Li;
- Liu, Bo;
- Qiu, Hong;
- Yuan, Xianglin
Publication type:
Article
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 519, doi. 10.1002/cac2.12406
By:
- Iwasa, Satoru;
- Wang, Zi‐Xian;
- Muro, Kei;
- Morita, Satoshi;
- Park, Young Suk;
- Zhang, Dongsheng;
- Yamada, Yasuhide;
- Sakamoto, Junichi;
- Kim, Tae Won
Publication type:
Article
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 415, doi. 10.1002/cac2.12411
By:
- Suzuki, Hiroyuki;
- Iwamoto, Hideki;
- Seki, Takahiro;
- Nakamura, Toru;
- Masuda, Atsutaka;
- Sakaue, Takahiko;
- Tanaka, Toshimitsu;
- Imamura, Yasuko;
- Niizeki, Takashi;
- Nakano, Masahito;
- Shimose, Shigeo;
- Shirono, Tomotake;
- Noda, Yu;
- Kamachi, Naoki;
- Sakai, Miwa;
- Morita, Kazutoyo;
- Nakayama, Masamichi;
- Yoshizumi, Tomoharu;
- Kuromatsu, Ryoko;
- Yano, Hirohisa
Publication type:
Article
Cover Image, Volume 43, Issue 4.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. i, doi. 10.1002/cac2.12424
By:
- Suzuki, Hiroyuki;
- Iwamoto, Hideki;
- Seki, Takahiro;
- Nakamura, Toru;
- Masuda, Atsutaka;
- Sakaue, Takahiko;
- Tanaka, Toshimitsu;
- Imamura, Yasuko;
- Niizeki, Takashi;
- Nakano, Masahito;
- Shimose, Shigeo;
- Shirono, Tomotake;
- Noda, Yu;
- Kamachi, Naoki;
- Sakai, Miwa;
- Morita, Kazutoyo;
- Nakayama, Masamichi;
- Yoshizumi, Tomoharu;
- Kuromatsu, Ryoko;
- Yano, Hirohisa
Publication type:
Article
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 508, doi. 10.1002/cac2.12402
By:
- Makris, Georgios;
- Kayhan, Semih;
- Kreuzer, Marvin;
- Rüfenacht, Véronique;
- Faccin, Erica;
- Underhaug, Jarl;
- Diez‐Fernandez, Carmen;
- Knobel, Philip A.;
- Poms, Martin;
- Gougeard, Nadine;
- Rubio, Vicente;
- Martinez, Aurora;
- Pruschy, Martin;
- Häberle, Johannes
Publication type:
Article
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 503, doi. 10.1002/cac2.12401
By:
- Shaurova, Tatiana;
- Yan, Lingyue;
- Su, Yafei;
- Rich, Laurie James;
- Vincent‐Chong, Vui King;
- Calkins, Hannah;
- Pokharel, Saraswati;
- Petkovich, Martin;
- Seshadri, Mukund;
- Wu, Yun;
- Hershberger, Pamela Anne
Publication type:
Article
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 513, doi. 10.1002/cac2.12405
By:
- Hao, Yang;
- Ma, Sen;
- Gu, Zili;
- Haghparast, Alireza;
- Schomann, Timo;
- Yu, Zhenfeng;
- He, Yuanyuan;
- Dong, Xiaoxv;
- Cruz, Luis J;
- ten Dijke, Peter
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2023, v. 43, n. 4, p. 413, doi. 10.1002/cac2.12301
Publication type:
Article